- Sale
1 x 10mg Multi Dose Sterile Vial
1 x 2ml Bacteriostatic Water Vial
Body Pharm Selank 10mg contains 10 mg of Selank, a synthetic heptapeptide originally developed for its potential effects on the brain and central nervous system.
Selank has primarily been studied for its anxiolytic (anxiety-reducing) properties and potential effects on stress response, cognitive function, and mental wellbeing. Research suggests that its activity may involve several neurological signalling systems, including GABA and endogenous enkephalin pathways.
Unlike conventional sedative anti-anxiety medications, Selank has been investigated for reducing anxiety while potentially maintaining mental alertness and cognitive function.
Selank has primarily been researched for potential support with:
Human clinical research has primarily focused on Selank's potential anxiolytic effects, with some studies also reporting mild nootropic and antiasthenic effects.
Selank appears to influence several signalling pathways within the central nervous system rather than acting through one single mechanism.
Research suggests that its activity may include:
Experimental research suggests that Selank may positively modulate GABA receptor activity, while other research has investigated its ability to influence the metabolism of naturally occurring enkephalins.
Its precise mechanisms and broader clinical effects remain under investigation.
Use this product only as directed by a healthcare professional or supervising practitioner.
Administration Route: Subcutaneous injection following appropriate reconstitution.
Body Pharm Selank contains 10 mg of Selank supplied as a peptide preparation for subcutaneous administration.
There is currently no well-established, universally accepted clinical dosing protocol for subcutaneous Selank.
Published human clinical studies of Selank have predominantly investigated intranasal administration, meaning those dosages should not automatically be converted or applied to a subcutaneous injectable product.
The appropriate dose, reconstitution volume, injection frequency, and duration for this product should therefore be determined by an appropriately qualified healthcare professional.
Available human research on Selank is relatively limited compared with established prescription medicines, particularly for subcutaneous administration. The complete adverse-effect profile has therefore not been established.
Potentially reported or anticipated effects may include:
You might also like